Intravenous NAD+ Reduces Post-Resuscitation Lung Injury in Swine Model

The transition from cardiac arrest to successful resuscitation triggers a complex cascade of systemic ischemia-reperfusion injury (tissue damage caused when blood supply returns to organs after a period of oxygen deprivation), often termed post-cardiac arrest syndrome [1, 2]. While return of spontaneous circulation is the primary goal, the subsequent surge in reactive oxygen species (unstable molecules that easily react with other cellular components) and peroxynitrite can cause overwhelming oxidative damage to vital organs [3, 4, 5]. The lungs are particularly vulnerable to this insult, frequently manifesting as acute injury driven by lipid peroxidation and iron-dependent cell death, a process known as ferroptosis [6, 7]. Current clinical management remains largely supportive, as the precise molecular mechanisms governing this pulmonary barrier dysfunction are still being elucidated [5, 2]. A new study in a porcine model investigates whether replenishing metabolic cofactors, specifically nicotinamide adenine dinucleotide (NAD+, a coenzyme central to cellular energy metabolism), can interrupt these lethal signaling pathways to preserve respiratory function after resuscitation [8].